Ruth Dreessen  was named to Gevo’s board of directors. Dreessen is an MD with Lion Chemical Capital. Khosla Ventures, Virgin Green Fund, Burrill & Co., Malaysian Life Sciences Capital Fund and Osage Partners have invested in Gevo, a biofuels company, which went public in 2011. PRESS RELEASE Gevo, Inc. (NASDAQ: GEVO), a leading renewable chemicals [...]

We at peHUB have written about emerging biofuels companies on a number of occasions in the past year, chronicling the rush of these still formative companies to the IPO window. Here is a useful “cheat sheet” courtesy of Lux Research on who the ultimate winners and losers could be. The biofuels and biochemical industries are [...]

The global downturn eventually put the skids on the ability of cleantech firms to raise cash. General partners found it hard to pitch LPs for new money when they could show little in the way of returns from past funds. Or so goes the prevailing wisdom. Stop here! Maybe this storyline isn’t as accurate as [...]

Venture-backed IPOs have gotten off to a strong start this year. So far, a dozen venture-backed companies have gone public, raising just over $1 billion in proceeds, according to Thomson Reuters (publisher of peHUB). For the same period a year earlier, just three companies went public, raising $379.5 million.

Which VC-backed stock has cratered 35 percent since its offering? Which one has soared nearly 49 percent? Check out our slideshow to find out.

(If you like the data, consider subscribing to Venture Capital Journal. In each issues, VCJ publishes even more detailed profiles of every VC-backed IPO, including the share holdings of VC backers. Click here for a free trial.)

Gevo Inc., an Englewood, Colo.-based developer of advanced biofuels like butanol, has filed for a $150 million IPO. It plans to trade on the Nasdaq, with UBS Investment Bank and Goldman Sachs serving as co-lead underwriter. The company reports a $7.86 million net loss for the year ending March 31, on $330,000 in revenue. Gevo [...]